Portal
Darby Kreienberg is a highly experienced Senior Research Associate with a strong background in various biotechnological and pharmaceutical research roles. Currently employed at Portal since June 2024, Darby previously held similar positions at Resonance Medicine, Inc., AvenCell, and TCR² Therapeutics Inc., where significant contributions included developing ELISA assays, optimizing CAR-T cell protocols, and utilizing CRISPR-Cas9 for gene editing. Academic experience includes research assistant roles at Northeastern University and Cleveland Clinic Lerner Research Institute, along with a strong foundation in biology from Case Western Reserve University and a master's degree in pharmacology from Northeastern University.
This person is not in any teams
Portal
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics